Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98527393 | 9852739 | 3 | F | 201307 | 20160707 | 20140129 | 20160719 | EXP | US-ACORDA-ACO_37871_2013 | ACORDA | 67.47 | YR | F | Y | 0.00000 | 20160719 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98527393 | 9852739 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | 13A940 | 22250 | 10 | MG | TABLET | BID | ||||
| 98527393 | 9852739 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Y | 22250 | TABLET | ||||||||||
| 98527393 | 9852739 | 3 | C | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 1 MG, QOD | U | 0 | 1 | MG | QOD | ||||||
| 98527393 | 9852739 | 4 | C | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 98527393 | 9852739 | 5 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, PRN | U | 0 | 50 | MG | |||||||
| 98527393 | 9852739 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 98527393 | 9852739 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, BID | U | 0 | 40 | MG | BID | ||||||
| 98527393 | 9852739 | 8 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 98527393 | 9852739 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98527393 | 9852739 | 1 | Multiple sclerosis |
| 98527393 | 9852739 | 2 | Gait disturbance |
| 98527393 | 9852739 | 3 | Multiple sclerosis |
| 98527393 | 9852739 | 4 | Gastrooesophageal reflux disease |
| 98527393 | 9852739 | 5 | Pain |
| 98527393 | 9852739 | 6 | Hypertension |
| 98527393 | 9852739 | 7 | Hypertension |
| 98527393 | 9852739 | 8 | Blood cholesterol abnormal |
| 98527393 | 9852739 | 9 | Neuropathy peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98527393 | 9852739 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98527393 | 9852739 | Blood chloride decreased | |
| 98527393 | 9852739 | Blood glucose increased | |
| 98527393 | 9852739 | Blood potassium decreased | |
| 98527393 | 9852739 | Dysphagia | |
| 98527393 | 9852739 | Hypoaesthesia | |
| 98527393 | 9852739 | Mastication disorder | |
| 98527393 | 9852739 | Oropharyngeal swelling | |
| 98527393 | 9852739 | Swollen tongue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98527393 | 9852739 | 1 | 20130610 | 20130705 | 0 |